FLT3 and acute myeloid leukemia: For instance, HO-1 has emerged as a significant prognostic marker in acute myeloblastic leukemia (AML), particularly in cases involving the Fms-Like Tyrosine Kinase Receptor 3 (FLT3) gene Internal Tandem Duplication (ITD) mutation, which is associated with poor outcomes.